molecule.xyz builds DeSci infrastructure that turns intellectual property into programmable on-chain assets to fund, govern and share biotech research.
molecule.xyz builds infrastructure for decentralized science (DeSci), converting intellectual property into programmable, on-chain assets that can be funded, governed and shared. The company's stated aim is to make scientific research more transparent and collaborative, and to challenge traditional drug-development funding models and institutional silos. Its work sits at the intersection of biotech, research funding and intellectual-property commercialisation.
Central to this is the IP-NFT framework, which tokenises intellectual property so that research outputs become tradable and governable assets. Around it sits an evolving stack of protocols designed to let researchers, patients and communities collaborate on biotech projects outside conventional funding channels. The Labs platform brings funding, collaboration and visible progress into a single place, so that projects can advance with fewer administrative obstacles and with sustained community support.
The company is trusted by frontier DeSci projects including VitaDAO, Cerebrum DAO, PsyDAO and ValleyDAO. Its technical work spans blockchain and on-chain assets, tokenisation of IP, protocol development and research-funding platforms.
molecule.xyz describes an open-ecosystem philosophy in which capital, data and expertise flow toward the most important research, with an inclusive orientation toward researchers, funders, patients and communities alike.
